An Alpha1-Antitrypsin Enhancer Polymorphism Is a Genetic Modifier of Pulmonary Outcome in Cystic Fibrosis

European Journal of Human Genetics - United Kingdom
doi 10.1038/sj.ejhg.5200623
Full Text
Abstract

Available in full text

Categories
Genetics
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

PstI Polymorphism of the Alpha1-Antitrypsin-Like Gene

Nucleic Acids Research
Genetics
1989English

Efficacy of Alpha1-Antitrypsin Augmentation Therapy in Conditions Other Than Pulmonary Emphysema

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2011English

Beta-Defensin Genomic Copy Number Is Not a Modifier Locus for Cystic Fibrosis

Journal of Negative Results in BioMedicine
GeneticsPharmacologyMolecular BiologyBiochemistryMedicineToxicologyPharmaceutics
2005English

Pulmonary Nocardiosis in an Immunocompetent Patient With Cystic Fibrosis

Case Reports in Pulmonology
2015English

Understanding Pulmonary Cystic Fibrosis

Journal of Lung, Pulmonary & Respiratory Research
2015English

The Pulmonary Microbiome in Cystic Fibrosis

2020English

Alpha1-Antitrypsin Deficiency and C-Jun

Hepatology
MedicineHepatology
2017English

Disparities in Cystic Fibrosis Care and Outcome

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2016English

Alpha1-Antitrypsin Deficiency and Liver Disease

BMJ
1981English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy